BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stein J, Haas JS, Ong SH, Borchert K, Hardt T, Lechat E, Nip K, Foerster D, Braun S, Baumgart DC. Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany - a real-world evidence analysis. Clinicoecon Outcomes Res 2018;10:93-103. [PMID: 29440920 DOI: 10.2147/CEOR.S150900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Hu S, Liu L, Pollock RF, Pöhlmann J, Wu D, Zhang Y. Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose. Journal of Medical Economics. [DOI: 10.1080/13696998.2022.2065092] [Reference Citation Analysis]
2 Shao Y, Luo W, Xu H, Zhang L, Guo Q. The Efficacy of Ferumoxytol for Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials. Acta Haematol 2019;142:125-31. [PMID: 31434073 DOI: 10.1159/000498937] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Argüelles-arias F, Bermejo F, Borrás-blasco J, Domènech E, Sicilia B, Huguet JM, de Arellano AR, Valentine WJ, Hunt B. Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain. Therap Adv Gastroenterol 2022;15:175628482210861. [DOI: 10.1177/17562848221086131] [Reference Citation Analysis]
4 Ueda N, Takasawa K. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease. Nutrients 2018;10:E1173. [PMID: 30150549 DOI: 10.3390/nu10091173] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
5 Kumar A, Brookes MJ. Iron Therapy in Inflammatory Bowel Disease. Nutrients 2020;12:E3478. [PMID: 33198376 DOI: 10.3390/nu12113478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jimenez KM, Gasche C. Management of Iron Deficiency Anaemia in Inflammatory Bowel Disease. Acta Haematol 2019;142:30-6. [PMID: 30970351 DOI: 10.1159/000496728] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
7 Winckel K, Sullivan S, Vongphakdi M, Snoswell CL. A retrospective review examining intravenous iron infusion dosing methods. J Pharm Pract Res 2021;51:225-30. [DOI: 10.1002/jppr.1698] [Reference Citation Analysis]
8 Golonka RM, Xiao X, Abokor AA, Joe B, Vijay-Kumar M. Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota. J Nutr Biochem 2020;80:108360. [PMID: 32163821 DOI: 10.1016/j.jnutbio.2020.108360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]